IT must now be said. The skeptics and Sinovac naysayers have been right all along. The Chinese vaccines against Covid-19 — be they Sinovac or Sinopharm — have low effectiveness rate and can reasonably be refused by prospective vaccinees on the grounds of efficacy and safety.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.